Bone density women depot medroxyprogesterone acetate contraception erratum BMJ Jul OBJECTIVE use injectable contraceptive depot medroxyprogesterone DMPA ovarian oestrogen production changes bone density DESIGN Population study DMPA users control groups population studies several putative determinants bone density age race body mass index years oestrogen deficiency Controls DMPA users prior knowledge bone density measurements SETTING Teaching hospital community family planning clinics SUBJECTS current users DMPA minimum years previous use premenopausal controls postmenopausal controls MAIN OUTCOME MEASURE Lumbar spine femoral neck bone mineral density dual energy ray absorptiometry RESULTS premenopausal controls age race body mass index DMPA users bone density lumbar spine mean difference confidence interval femoral neck postmenopausal controls body mass index duration oestrogen deficiency DMPA users bone density lumbar spine femoral neck difference bone density CONCLUSIONS Women DMPA density values normal premenopausal postmenopausal controls degree oestrogen deficiency DMPA adverse effect bone density 